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Fluorescence resonance energy transfer (FRET) was used to monitor interactions between Cy3-labeled plasmid DNA and NBD-labeled
cationic liposomes. FRET data show that binding of cationic liposomes to DNA occurs immediately upon mixing (within 1 min), but FRET
efficiencies do not stabilize for 1–5 h. The time allowed for complex formation has effects on in vitro luciferase transfection efficiencies of
DOPE-based lipoplexes; i.e., lipoplexes prepared with a 1-h incubation have much higher transfection efficiencies than samples with 1-min or
5-h incubations. The molar charge ratio of DOTAP to negatively charged phosphates in the DNA (DOTAP+/DNA) also affected the
interaction between liposomes and plasmid DNA, and interactions stabilized more rapidly at higher charge ratios. Lipoplexes formulated with
DOPE were more resistant to high ionic strength than complexes formulated with cholesterol. Taken together, our data demonstrate that lipid–
DNA interactions and in vitro transfection efficiencies are strongly affected by the time allowed for complex formation. This effect is especially
evident in DOPE-based lipoplexes, and suggests that the time allowed for lipoplex formation is a parameter that should be carefully controlled
in future studies.D 2003 Elsevier B.V. All rights reserevd.Keywords: Gene delivery; Nonviral vector; Stability; Fluorescence resonance energy transfer1. Introduction
Problems associated with the use of viruses as gene
delivery vehicles have renewed an interest in developing
synthetic vectors with minimal immunogenicity [1–4].
Although transfection studies are careful to control certain
parameters in the preparation of nonviral vectors (e.g.,
charge ratio, mixing conditions, DNA concentration), the
time allowed for vectors to assemble is not typically
optimized. This general statement is true for both in vitro0005-2736/03/$ - see front matter D 2003 Elsevier B.V. All rights reserevd.
doi:10.1016/S0005-2736(03)00177-9
Abbreviations: FRET, fluorescent resonance energy transfer; DOTAP,
N-(1-(2,3-dioleoyloxy)propyl)-N,N,N-trimethylammonium chloride;
DOPE, 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine; POPC, 1-
palmitoyl-2-oleoyl-sn-glycerophosphocholine; NBD-PE, 7-nitrobenzo-2-
oxa-1,3-diazol-4-yl phosphatidylethanolamine; DOTAP+/DNA, molar
charge ratio of DOTAP to negatively charged phosphates in the DNA;
SDS, sodium dodecylsulfate; La
C, multilamellar structure; HII
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lattice
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E-mail address: Ye.Zhang@UCHSC.edu (Y. Zhang).and in vivo studies, and some clinical trials have employed
pre-assembled vectors while others prepare complexes im-
mediately prior to injection into the patient [5,6]. In an
attempt to investigate the effects of complexation time on
lipid–DNA complexes (lipoplexes), our study utilizes fluo-
rescent resonance energy transfer (FRET) to examine the
time-dependent interaction of cationic liposomes with plas-
mid DNA. In addition, we compare the changes we observe
with FRET to alterations in NaCl sensitivity, transfection,
and particle size.
Cationic liposomes used for gene delivery typically
incorporate neutral helper lipids in order to increase the
transfection efficiency of the resulting lipid–DNA com-
plexes. It has been reported that dioleoylphosphatidyletha-
nolamine (DOPE) increases the in vitro transfection
efficiency, and cholesterol gives significant enhancement
in vivo [7,8]. DOPE has a small head group and bulky acyl
chains, which gives it a high propensity to form a hexag-
onal phase and promote membrane fusion [9–12]. Fusion
of lipoplexes with the endosomal membrane is thought to
result in cytosolic release of DNA and subsequent en-
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of cholesterol on membrane structure have reported that
cholesterol also promotes hexagonal phase formation
[16,17]. However, other studies suggest that the lipids in
cholesterol-based lipoplexes have a stable and rigid lamel-
lar structure that does not readily fuse with lipid bilayers
[18,19].
The electrostatic interactions between cationic liposomes
and negatively charged nucleic acids result in spontaneous
formation of lipoplexes [20,21]. The process of complexa-
tion is dynamic and has been shown to induce structural
changes in both DNA and cationic liposomes [20–22].
However, the time needed for lipoplexes to stabilize is not
well-studied, and various equilibration times (0–60 min)
have been employed by different researchers [6,20,23–29].
A study by Gershon et al. [24] monitored ethidium bromide
intercalation and showed that complexes at DOTAP+/DNA
of 1.1 became stable after 40 min, while complexes at charge
ratios of 0.5 and 1.5 stabilized within seconds. Their results
suggest that the association between lipids and DNA in a
lipoplex can fluctuate over time. Therefore, the time allowed
for complexation is an experimental variable that can affect
the physical properties of lipoplexes, and it seems prudent to
investigate lipid–DNA interactions during complex forma-
tion more fully.
Previous studies have utilized FRET to evaluate the
interaction between cationic lipids and DNA [30–34]. FRET
can be observed when a fluorescently labeled lipid and DNA
are in close proximity (approximately 2–9 nm), and is
prevented upon dissociation [35]. Since FRET efficiency is
inversely related to the sixth power of distance between the
donor and acceptor probes, changes in FRET efficiency
reflect alterations of the lipid and DNA interaction. FRET
was determined by monitoring the decrease in fluorescence
emission of 7-nitrobenzo-2-oxa-1,3-diazol-4-yl-phosphati-
dylethanolamine (NBD-PE) in the presence of the Cy3-
DNA. In this work, we describe the use of NBD and Cy3
as fluorescent probes for monitoring lipid–DNA interactions
by FRET. In addition, we report the results of experiments
utilizing this technique, to investigate the effects of incuba-
tion time, DOTAP+/DNA charge ratio, and ionic strength
on the stability of lipid–DNA interactions. Finally, we assess
the effects of incubation time and DOTAP+/DNA charge
ratio on particle size and in vitro cell transfection efficiency
in an effort to elucidate the role of lipid–DNA interactions in
biological activity.2. Materials and methods
2.1. Plasmid DNA and lipids
Plasmid DNA (5 kb, >90% supercoiled) encoding green
fluorescent protein under control of the cytomegalovirus
promoter (pGreen lantern-1; Gibco-BRL), was propagated
in E. coli and purified by Aldevron Custom Plasmid Purifi-cation (Fargo, ND). Luciferase plasmid DNA is a kindly gift
from Valentis Inc. (Burlingame, CA). N-(1-(2,3-dioleoylox-
y)propyl)-N,N,N-trimethylammonium chloride (DOTAP),
1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine
(DOPE), cholesterol, 1-palmitoyl-2-oleoyl-sn-glycerophos-
phocholine (POPC) and NBD-PE were purchased from
Avanti Polar Lipids (Alabaster, AL). Cy3 Label IT kits used
for covalent labeling of plasmid DNA were acquired from
Mirus (Madison, WI). The luciferase assay kit was bought
from Promega (Madison, WI).
2.2. Preparation of labeled liposomes and DNA
DOTAP, combined with DOPE or cholesterol (1:1 mole
ratio), was mixed in chloroform with NBD-PE, to achieve a
final concentration of 2.6 mol% labeled lipid. The lipid
mixture was dried under a stream of nitrogen gas and placed
under vacuum (10 mTorr) for 2 h to remove residual
chloroform, and dried lipids were subsequently resuspended
in autoclaved, distilled water. Cationic liposomes containing
NBD-PE were prepared the day before the experiment,
stored overnight at 4 jC, and sonicated immediately before
use. DNA labeling with Cy3 was carried out following the
protocol provided by the manufacturer. Briefly, DNA and
labeling reagent were mixed in Hepes buffer (25 mM Hepes,
1 mM EDTA, pH 7.5) and incubated for 1 h at 37 jC.
Unreacted labeling reagent was removed by NaCl/ethanol
precipitation. The labeled DNA was redissolved in 2.5 mM
Hepes buffer and quantitated by UV absorbance at 260 nm.
The fluorescence of Cy3-DNAwas measured and compared
to the Cy3 standard curve to determine the extent of Cy3-
labeling on DNA. Utilizing this procedure, a Cy3 label
concentration of 2.6% (w/w) of plasmid DNAwas obtained,
and used in our experiments. At these concentrations of
fluorescent probes, we do not observe self-quenching of the
NBD-lipid or the Cy3-DNA, consistent with previous stud-
ies [36] and manufacturer’s information (Mirus). Further-
more, the absence of any effects due to the labeling density
and/or lipoplex concentration used in our experiments was
demonstrated in separate experiments where virtually iden-
tical time- and charge ratio-dependent trends were observed
despite either a 50% reduction in labeled lipid concentration
or a 10-fold increase in DNA concentration (data not
shown).
2.3. Preparation of lipoplexes
Lipoplexes with different DOTAP+/DNA charge ratios
were prepared by adding different volumes of our stock
lipid suspension (50 Ag/ml DOTAP in addition to helper
lipid in a 1:1 molar ratio) into 10 Al 16.7 Ag/ml DNA
solution. The suspension was subsequently diluted in 2.5
mM Tris–HCl buffer (pH 7.8) to reach a final volume of
500 Al. The final DNA concentration in the lipoplexes was
held constant at 0.334 Ag/ml (1 AM DNA phosphate) in all
of our experiments.
Fig. 1. The fluorescence spectra of NBD andCy3 in 2.5mMTris–HCl buffer
(pH 7.8): excitation spectrum of NBD-PE (closed circle); emission spectrum
of NBD-PE (open circle); excitation spectrum of Cy3-DNA (closed square);
emission spectrum of Cy3-DNA (open square).
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FRET was determined by monitoring the decrease in
fluorescence of NBD-PE (donor) in the presence of the Cy3-
DNA (acceptor) on an Aviv automated titrating differential/
ratio spectrofluorometer (model ATF105). Data are reported
as efficiency of FRET, which is calculated according to the
equation:
E ¼ 1 FDA=FD
where FDA and FD are the fluorescence intensity of the
NBD-PE (excitation at 463 nm and emission at 528 nm) in
the presence of Cy3-DNA and unlabeled DNA, respectively.
To minimize potential problems associated with aggre-
gation that could complicate interpretation of our data,
experiments were performed at low DNA concentrations
(0.334 Ag/ml).
2.5. In vitro transfection assay
African green monkey kidney cells (COS-7: ATCC No.
CRL1651) were obtained from American Type Culture
Collection (Rockville, MD). Cells were incubated at 37 jC
in a humidified atmosphere containing 5% CO2. Cells were
maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum, 50
U/ml penicillin G, and 50 g/ml streptomycin sulfate, and
were propagated by reseeding at 1–3105 cells/100-mm
dish every 2–3 days. For in vitro transfection, cultures were
freshly seeded at 2500 cells/well in 96-well plate 24 h before
transfection. Lipoplexes (20 Al) containing 0.2 Ag DNAwere
incubated at room temperature for 1 min, 1 and 5 h before
applying to wells containing freshly washed (twice with
phosphate-buffered saline, PBS) COS-7 cells in 80
Al serum-free, antibiotic-free DMEM. The cells were incu-
bated with lipoplexes for 4 h before the medium was
replaced with 100 Al DMEM containing serum and anti-
biotics as previously described [37]. Forty hours after
transfection, the culture medium was discarded, and the cells
were washed twice with 100 Al PBS and then lysed with 20
Al of lysis buffer (Promega). A single freeze–thaw was
performed to ensure complete lysis. Twenty microliters of
cell lysis solution were used to assay for luciferase expres-
sion using the luciferase assay kit (Promega), according to
the manufacturer’s protocol. The signal was quantified using
a TD-20e Luminometer (Turner Designs, Inc., Mountain
View, CA).
2.6. Dynamic light scattering analysis
Samples (20 Al) containing 0.5 Ag plasmid and corres-
ponding liposomes were prepared with equal volumes of
DNA and cationic lipids and incubated at room temperature
for 1 min, 1 and 5 h before diluting to 500 Al with 2.5 mM
Tris buffer. Diluted samples were transferred to a cuvette for
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cron Particle Sizer (Particle Sizing Systems, Santa Barbara,
CA). Channel width was set automatically based on the rate
of fluctuation of scattered light intensity. The data were
volume-weighted, and the analysis assumed that lipoplexes
are solid particles [38].3. Results
3.1. FRET experimental conditions
Preliminary studies attempted to utilize NBD-labeled
liposomes and carboxy-rhodamine-labeled DNA to monitor
lipid–DNA interactions by FRET. In our hands, an increase
in carboxy-rhodamine emission was readily observed by
exciting NBD-labeled lipid, indicating that FRET had
occurred between the two probes. However, no corres-
ponding decrease in the NBD emission was observed, as
would be expected if energy is transferred from the NBD-
labeled liposome to the rhodamine-labeled DNA. A search
for other fluorescent probes that exhibited FRET as indicat-
ed by both a decrease in donor probe emission and a cor-
responding increase in acceptor probe emission, revealed
that NBD-labeled liposomes combined with Cy3-labeled
DNA satisfied this criterion. To our knowledge, the use of
this pair of fluorescent probes to monitor FRET has not been
previously reported.
The excitation and emission spectra of NBD-PE and Cy3-
DNA are illustrated in Fig. 1. The donor probe, NBD, has an
excitation maximum at 463 nm and an emission peak at 528
nm. The acceptor probe, Cy3, emits at 565 nm with an
excitation maximum near 545 nm. As shown in Fig. 1, there
is more than 90% overlap between the excitation spectrum of
Cy3 and the emission spectrum of NBD. This overlap allows
FRET to occur when the two probes are separated by a
distance comparable to the Fo¨rster distance (approximately
2–9 nm).
Y. Zhang et al. / Biochimica et Biophysica Acta 1614 (2003) 182–192 185Fig. 2 shows the decrease in fluorescence emission of
NBD-labeled liposomes and the corresponding increase in
fluorescence emission of Cy3-labeled DNA, indicating that
resonance energy is successfully transferred from donor to
acceptor. In monitoring the Cy3-DNA emission maximum
from lipoplexes containing both Cy3-DNA and NBD-lip-
osomes, a slight red shift of approximately 6 nm is observed
(Fig. 3A). In contrast, the emission maximum of NBD-PE-
lipid exhibits only a decrease in the fluorescence intensity,
with no shift of the peak (Fig. 3B). In experiments utilizing
FRET to assess lipid–DNA interactions, the FRET efficien-
cy was monitored by following the decrease in NBD-PE
emission maximum as demonstrated in Fig. 3B. In the
calculation of FRET efficiency, previous researchers
[30,32] appear to have used a value for FD that is the
measured fluorescence intensity of the donor-labeled mole-
cule (in our case, NBD-PE) in the absence of any acceptor-Fig. 2. (A) Fluorescence emission spectra of NBD-PE:DOTAP-DOPE, Cy3-
DNA and the lipoplexes (NBD-PE:DOTAP-DOPE in the presence of Cy3-
DNA and unlabeled DNA, respectively) in 2.5 mM Tris–HCl buffer (pH
7.8): Lipoplex 1 (NBD-PE:DOTAP-DOPE and Cy3-DNA mixture, open
circle); NBD-PE:DOTAP-DOPE alone (closed circle); Lipoplex 2 (NBD-
PE:DOTAP-DOPE and unlabeled DNAmixture, closed triangle); Cy3-DNA
alone (open triangle); (B) Fluorescence emission spectra of NBD-
PE:DOTAP-cholesterol, Cy3-DNA and the lipoplexes (NBD-PE:DOTAP-
cholesterol in the presence of Cy3-DNA and unlabeledDNA, respectively) in
2.5 mM Tris–HCl buffer (pH 7.8): Lipoplex 3 (NBD-PE:DOTAP-choles-
terol and Cy3-DNA mixture, open circle); NBD-PE:DOTAP-cholesterol
alone (closed circle); Lipoplex 4 (NBD-PE:DOTAP-cholesterol and
unlabeled DNA mixture, closed triangle); Cy3-DNA alone (open triangle).
All lipoplexes were prepared at a DOTAP+/DNA charge ratio of 1.
Fig. 3. (A) Emission spectra of Cy3-DNA (closed circle), and lipoplex of
NBD-PE:DOTAP-DOPE and Cy3-DNA mixture (open circle) excited at
528 nm; (B) Emission spectra of NBD-PE:DOTAP-DOPE (closed circle),
and lipoplex of NBD-PE:DOTAP-DOPE and unlabeled DNA mixture (open
circle) excited at 463 nm. Lipoplexes were prepared at a DOTAP+/DNA
charge ratio of 1.labeled molecule (in our case, Cy3-DNA). Considering that
the microenvironment of the probes can significantly affect
their fluorescent properties, this approach assumes that the
microenvironment of the donor probe is unaltered by com-
plex formation. While this assumption may be valid for
certain conditions, our results with the lipid–DNA system
indicate that the fluorescence of NBD-lipids is altered by
complexation (Fig. 2). For example, the fluorescence emis-
sion of NBD-PE in DOTAP-cholesterol liposomes at 528 nm
shows no change when complexed with Cy3-DNA, suggest-
ing no energy transfer between NBD-PE:DOTAP-cholester-
ol and Cy3-DNA. However, an increase in Cy3-DNA
emission is observed in the same condition, which indicates
that energy transfer between NBD-lipid and Cy3-DNA has
occurred (Fig. 2B). This discrepancy can be explained by a
change in the fluorescent probe’s environment that causes
higher fluorescence emission of NBD-PE:DOTAP-choles-
terol after complexation with DNA. Thus, FRET efficiency
calculations are most accurate when NBD-PE:DOTAP-cho-
lesterol complexed with unlabeled DNA is used as the value
for FD. Similarly, complexation with unlabeled DNA
increases the intensity of NBD-PE in DOTAP-DOPE lip-
osomes, but the increase is not as great as that observed with
Fig. 4. The dynamic change of FRET efficiency between NBD-lipids and
Cy3-DNA at DOTAP+/DNA charge ratio 0.5 (panel A), 1 (panel B) and 2
(panel C). DOTAP-DOPE (closed circle); DOTAP-cholesterol (open circle)
and POPC (triangle). Insets: expanded X-axis of the first 5 h.
Fig. 5. Effect of DOTAP+/DNA ratio on the FRET efficiency between
NBD-lipids and Cy3-DNA after a 1 min (closed circle), 1 h (open circle)
and 5 h (triangle) incubation. (A) DOTAP-DOPE; (B) DOTAP-cholesterol.
Insets: expanded X-axis from charge ratio 0.1 to 2.
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effects are consistent with previous studies demonstrating
that the choice of helper lipid contributes to lipoplex struc-
ture [16]. To account for structural changes that might alter
fluorescence, NBD-labeled liposomes complexed with un-
labeled DNA were utilized to determine the value for FD
used to calculate FRET.
In the scenario depicted above, any changes in fluores-
cence intensity resulting from complexation should be fully
reversible upon dissociation of the lipoplexes. In order to
test for reversibility, 0.05 M sodium dodecylsulfate (SDS),
which has been shown to dissociate cationic lipids from
DNA [37], was added to NBD-PE:DOTAP-DOPE/Cy3-
DNA lipoplexes, and NBD-PE:DOTAP-DOPE liposomes.
After boiling for 5 min, the fluorescence emission intensities
of samples were measured and compared to each other. Theresults showed that the fluorescence intensity at 528 nm was
not significantly different in these samples, indicating that
alterations in fluorescence upon complexation are fully
reversible upon dissociation of the lipoplexes (data not
shown). The dissociation of lipoplexes by SDS was verified
by agarose gel electrophoresis (data not shown).
3.2. Time course of complexation
DOTAP-DOPE/DNA and DOTAP-cholesterol/DNA lip-
oplexes were prepared at DOTAP+/DNA ratios of 0.5, 1,
and 2, and FRET efficiency was followed for 24 h to
investigate the kinetics of the complexation process. As
shown in Fig. 4, FRET measurements indicate that DNA
and cationic liposomes interact immediately after mixing
(within 1 min). However, the fluorescent signal does not
stabilize for 1–5 h. More specifically, FRET efficiency did
not stabilize for approximately 5, 4, and 1 h(s) in lipoplexes
prepared at charge ratios of 0.5, 1, and 2, respectively (Fig.
4). These findings suggest that higher concentrations of
cationic liposomes (relative to DNA) stabilize interactions
within the lipoplexes, and shorten the time necessary to
achieve a stable structure. Furthermore, in all three charge
ratios tested, the most significant changes happened within
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osomes, there was essentially no FRET between DNA and
neutral liposomes composed of POPC (Fig. 4B), consistent
with previous studies demonstrating that electrostatic inter-
actions are responsible for lipoplex formation [20,21].
3.3. The effect of charge ratio on FRET
Another parameter that is commonly varied in transfec-
tion studies is the DOTAP+/DNA charge ratio. To investi-
gate the effects of this parameter on lipid–DNA interactions,
FRET efficiency was monitored at charge ratios from 0.1 to
20 in lipoplexes. Considering that interactions within the
lipoplex vary over the first 5 h (Fig. 4), FRET efficiency ofFig. 6. Effect of NaCl concentration on the FRET efficiency of lipoplexes at DOT
circle), 1 h (open circle) and 5 h (triangle) incubation. A–C, DOTAP-DOPE; D–lipoplexes was monitored at three time points: 1 min, 1 and 5
h after mixing. In DOTAP-DOPE/DNA lipoplexes, FRET
efficiency is maximized at an DOTAP+/DNA ratio of
approximately 1 (Fig. 5A). Although incubation time of
DOPE-based complexes had little effect on FRET efficien-
cies at different charge ratios, samples given a 5-h incubation
exhibit the highest FRET efficiency (0.72 at DOTAP+/
DNA=1). FRET efficiency declines progressively in each
of these lipoplexes above neutrality, consistent with a bind-
ing saturation at the DNA–lipid interface followed by a
decreasing fraction of the lipids having access to DNA (Fig.
5A). In contrast, maximum FRET efficiency (c0.4) is
achieved at a charge ratio of 0.2 in DOTAP-cholesterol/
DNA lipoplexes and maintained at this level up to a chargeAP+/DNA ratios of 0.5 (A, D), 1 (B, E) and 2 (C, F) after a 1 min (closed
F, DOTAP-cholesterol.
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behaviors are observed for lipoplexes containing cholesterol
as compared to DOPE.
3.4. Ionic strength effects on lipid–DNA interactions
Salt has been implicated as a contributing factor in
facilitating lipoplex dissociation, and there are conflicting
reports in the literature regarding the effect of salt on lipoplex
stability [22,39,40]. In fact, high salt (2 M) has been used to
dissociate nonviral vectors prior to analysis of DNA tertiary
structure [41,42]. To investigate the effect of increasing NaCl
concentrations on lipid–DNA interactions, FRET efficiency
was monitored using lipoplexes prepared at three different
DOTAP+/DNA ratios (0.5, 1, 2) and incubated in NaCl
solutions ranging in concentration from 0 to 2 M (Fig. 6). As
in the previous experiments, three different incubation times
(1 min, 1 and 5 h) were used to study both DOPE- and
cholesterol-based lipoplexes. It is important to note that
lipoplexes are originally prepared as suspensions lacking
NaCl, incubated for 1 min, 1 or 5 h, and then incubated in
appropriate salt solutions for an additional h prior to FRET
analysis. Thus, these experiments are designed to assess the
ability of salt to dissociate lipoplexes that are formed in the
absence of NaCl. For DOTAP-DOPE/DNA lipoplexes at
DOTAP+/DNA ratios of 0.5 and 1, low concentrations of
NaCl (0.01–0.5 M) increase the FRET efficiency, while
higher concentrations decrease FRET efficiency, suggesting
that low NaCl concentrations enhance lipid–DNA interac-
tions, and high salt concentrations weaken the association
between lipid and DNA (Fig. 6A,B). However, even at 2 M
NaCl, FRET efficiency remains at approximately 0.4, indi-
cating that although some dissociation occurs, complexes are
still largely intact. In contrast, low salt has little effect at high
charge ratios, although high NaCl concentrations have a
greater ability to dissociate lipoplexes under these conditions
(Fig. 6C). With the exception of neutral lipoplexes at low
salt, incubation time had little effect on the ability of salt toFig. 7. Effect of incubation time and charge ratio on in vitro transfection efficien
ratios of 0.5 (white bars), 1 (gray bars), and 2 (black bars).dissociate DOPE-based complexes. Curiously, at charge
ratio of 0.5, a slightly greater resistance to salt was observed
with longer incubation times, but this trend is not evident at
higher charge ratios (Fig. 6A–C).
For DOTAP-cholesterol/DNA lipoplexes (Fig. 6D–F),
low NaCl concentrations (0.01–0.2 M) increase FRET
efficiency, and higher concentrations (z0.5 M) decrease
FRET efficiency; similar to that observed with DOPE-based
complexes. However, incubation time has clear effects on
FRET efficiency for lipoplexes prepared at DOTAP+/DNA
ratio of 0.5 incubated at low NaCl concentration (<0.5 M).
FRET efficiency at high salt is lower in cholesterol-based
lipoplexes than that in DOPE-based lipoplexes, suggesting
that the choice of helper lipid can have effects on disassem-
bly in addition to lipoplex formation.
3.5. Incubation time and charge ratio on in vitro trans-
fection efficiency
Our FRET data have shown that incubation time and
charge ratio have effects on the interaction between DNA
and cationic lipids. We also conducted experiments to
determine whether incubation time affected in vitro trans-
fection in COS-7 cells. Our results indicate that incubation
time plays an important role in transfection by DOPE-based
lipoplexes (Fig. 7). The high variability in luciferase expres-
sion observed in samples prepared with a 1-min incubation is
consistent with the instability of lipoplexes during the initial
period of complexation. The in vitro luciferase expression
increases several fold after a 1-h incubation as compared to a
1-min incubation at all DOTAP+/DNA ratios (Fig. 7). Five-
hour incubations produced lipoplexes with more consistent,
but lower transfection efficiencies (Fig. 4). For cholesterol-
based lipoplexes, no distinct differences in transfection
efficiency were found among lipoplexes prepared with three
incubation periods, but the very low luciferase expression for
lipoplexes at charge ratios of 0.5 and 1 makes it difficult to
observe changes in transfection efficiency under these con-cy of DOTAP-DOPE and DOTAP-cholesterol lipoplexes. DOTAP+/DNA
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charge ratio 2 exhibited relatively constant transfection
efficiencies, consistent with the minor changes in FRET
observed at different incubation times (Fig. 4C). Taken
together, the FRET efficiency and in vitro transfection
efficiency data suggest that incubation time plays an impor-
tant role in lipid–DNA interactions that is reflected by
changes in transfection efficiency.
3.6. Incubation time and charge ratio on particle size
It is well known that lipoplex size is a major determinant
of in vitro transfection efficiency [43,44]. To test if the
variation in transfection was a result of complex aggregation,
particle size was measured for lipoplexes prepared at differ-
ent DOTAP+/DNA ratios (0.5, 1 and 2) and incubation
times (1 min, 1 and 5 h). The results showed that lipoplexes
prepared with a 1-min incubation had larger particle sizes as
compared to those with 1- or 5-h incubations, with the
exception of cholesterol-based lipoplexes at charge ratio 2.
After a 1-h incubation, lipoplex size appeared to stabilize,
and only minor differences were seen after a 5-h incubation.
Taken together, these measurements indicate that the higher
transfection efficiency observed with lipoplexes incubated
for 1 h is not due to changes in particle size. Instead, we
suggest that subtle rearrangements in the lipid–DNA inter-
actions, as reflected in the FRET experiments, may be
responsible for the observed differences in transfection.4. Discussion
The lipids used in this study were modified with the NBD
probe covalently attached to the PE head group. As a result,
the cationic liposomes employed in this study have the
fluorescent probe located at the lipid–water interface. It
has been shown by Barenholz et al. [22,45] that the interac-
tion of DNA with cationic liposomes primarily affects the
region close to the lipid–water interface. Therefore, the
location of the fluorophore on the head of the lipid should
accurately reflect the extent of interaction between the DNA
and lipids. Previous studies have shown that electrostatic
interactions between cationic liposomes and DNA cause each
component to dehydrate during lipoplex formation
[20,22,46,47]. Dehydration likely affects the fluorescence
properties of the probes, and must be considered when
determining FRET. In addition, fluorescence is sensitive to
the polarity of the microenvironment; the fluorescence quan-
tum yield of NBD is low in aqueous solutions and high in
hydrophobic environments [48]. Thus, alteration of the
microenvironment by dehydration and/or partial burial in
the acyl chain region of the membrane, might explain the
enhanced fluorescence observed upon binding to unlabeled
DNA (Figs. 2 and 3). Regardless of the exact mechanism
responsible for the altered fluorescence properties, it is
important that such studies utilize lipoplexes with unlabeledDNA, rather than liposomes alone, to calculate FRET effi-
ciency more accurately. Under these conditions, the fluores-
cence intensity of NBD-PE:DOTAP-cholesterol emission in
the presence of unlabeled DNA is about 1.5 times that
observed in the absence of unlabeled DNA. Calculation of
FRET efficiencies using the traditional labeled liposome
reference would result in a value of zero for DOTAP-
cholesterol/DNA complexes despite a distinct increase in
the fluorescence intensity of Cy3-DNA emission which can
only be explained by FRET (Fig. 2B). In comparison, NBD-
PE:DOTAP-DOPE complexed with unlabeled DNA in-
creases the fluorescence intensity of NBD emission by
32% (Fig. 2A). In this case, the traditional calculation would
yield FRET efficiencies that are 14% lower than those
computed when effects of complexation on the NBD micro-
environment are considered. The observation that NBD
fluorescence is affected more by DNA binding to DOTAP-
cholesterol than DOTAP-DOPE liposomes is consistent with
a greater degree of dehydration in the former case [22].
Perhaps the finding that is most relevant to gene delivery
is that the association of lipid with DNA in a lipoplex is not
stable immediately upon complex formation. Instead, results
from FRET experiments suggest that associations within the
lipoplex may require up to 5 h to stabilize. The time required
for stabilization is dependent on both DOTAP+/DNA
charge ratio and the nature of the helper lipid (Fig. 4). FRET
efficiencies are clearly more stable at higher charge ratios,
suggesting that the kinetics of lipid–DNA binding contrib-
ute to the observed instability. The fact that FRET efficiency
fluctuates with time instead of progressively increasing
indicates that structural rearrangements that alter the asso-
ciation between lipid and DNA continue to occur after
binding is achieved (Fig. 4). It is interesting that in vitro
transfection efficiency was higher with lipoplexes given a 1-
h incubation as compared to samples for either 1-min or 5-
h incubations (Fig. 7). Furthermore, these differences do not
appear to be related to changes in particle size of the
lipoplexes (Fig. 8).
Our findings are consistent with reports by Yang and
Huang [27,49], who showed that increases in the DOTAP+/
DNA charge ratio and extension of the time (up to 1 h)
allowed for complexation can be used to overcome instabil-
ity in media containing serum. These authors described this
‘‘maturation’’ process in terms of the ability of complexes to
maintain transfection rates, and we suggest that our FRET
measurements reflect a similar process during which struc-
tural alterations occur within the lipoplex that contribute to
biological activity. Since the time allowed for complexation
is not a parameter that is typically monitored closely, such
time-dependent structural changes might contribute to the
high variability in transfection rates that is often observed.
Therefore, we suggest that variability in transfection rates
might be reduced if future studies employ protocols that
strictly regulate complexation time. This is particularly
important in light of our results showing that transfection
efficiency of lipoplexes incubated for prolonged periods (5
Fig. 8. Effect of incubation time and charge ratio on particle size of DOTAP-DOPE and DOTAP-cholesterol containing lipoplexes. DOTAP+/DNA ratios of
0.5 (white bars), 1 (gray bars), and 2 (black bars).
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times (Fig. 7).
Previous studies have also reported time-dependent
changes after cationic liposomes interact with DNA; how-
ever, these reports have primarily described changes occur-
ring within the first minute after mixing. Using time-resolved
multiangle laser light scattering, Eva and van Zanten [50]
demonstrated that lipoplex formation is kinetically con-
trolled and governed by charge ratio. These authors con-
cluded that lipoplexes eventually reach a stable state within a
few minutes. Similarly, Barreleiro et al. [51] utilized a
stopped-flow technique and showed that interactions hap-
pened on a millisecond time scale, and that relatively stable
multilamellar structures were formed on a time scale of
minutes. Although these studies employed very different
experimental techniques than the FRET approach used in our
study, the findings consistently demonstrate that lipoplex
structure continues to evolve after the initial binding event.
Thus, it seems prudent to consider complexation time as a
variable that should be controlled and optimized for individ-
ual experimental conditions. Furthermore, the significant
structural alterations observed in the early minutes of lip-
oplex formation suggest that clinical results might be altered
substantially if samples were not injected immediately after
complex formation [5,6].
Our data also clearly show that peak FRET efficiencies
are not observed at the lowest DOTAP+/DNA ratios tested,
as would be expected if lipid binding to DNAwas strongest
under conditions where DNAwas in excess (Fig. 5). Instead,
the results suggest that the accumulation of a given amount
of lipid on the plasmid induces a structural transition that
allows more intimate lipid–DNA interactions. This conclu-
sion is bolstered by our experiments with circular dichroism
(data not shown) and consistent with previous studies
demonstrating alterations in DNA structure upon complex
formation [47,48,52–54].
Lipoplexes are usually prepared in low ionic strength
solution in order to minimize precipitation. It has been
reported that precipitation caused by high ionic strength ismore pronounced during lipoplex formation than in the
preformed lipoplexes [55]. In this study, lipoplexes were
prepared in the absence of NaCl, and then the disassembly at
different ionic strengths was assessed. At low ionic strength
(0.01–0.5 M), there is an increase in FRET efficiencies at
DOTAP+/DNA ratios of 0.5 and 1 in DOTAP-DOPE lip-
oplexes, suggesting enhanced association of cationic lip-
osomes with DNA under these conditions (Fig. 6A,B). These
observations can be explained by the charge-shielding of
DNA phosphates that is thought to enhance DNA binding to
cationic liposomes at low ionic strength [56,57]. At a charge
ratio of 2 in DOTAP-DOPE lipoplexes, there is no signifi-
cant change in FRET efficiencies from 0.01 to 0.5 M NaCl
concentration with different incubation time periods, sug-
gesting maximal association occurs simultaneously with
lipoplex formation (Fig. 6C). This effect at high DOTAP+/
DNA might be related to more rapid ‘‘maturation’’ of
lipoplexes under these conditions, as described by Yang
and Huang [27]. These findings are also consistent with
reports that reduced DOTAP+/DNA ratios are required for
lipoplex formation at low ionic strength as compared to high
ionic strength [40].
Our results with cholesterol are much different from those
observed with DOPE-based complexes (Figs. 4–8). The
different effects observed with lipoplexes prepared with
DOPE versus cholesterol might result from the distinctly
different structures that are formed when these helper lipids
are employed [15,18,19,58]. For example, studies with small
angle X-ray scattering studies by Koltover et al. [15] have
demonstrated that mixing DNAwith cationic liposomes can
lead to lipoplexes with either a multilamellar structure (La
C) or
a columnar inverted hexagonal lattice (HII
C). DOPE induces
the La
C!HIIC structural transition by controlling the spontane-
ous curvature of the lipid monolayer. In contrast to La
C
lipoplexes, HII
C lipoplexes more easily fuse with anionic
vesicles and release DNA, resulting in increased transfection
efficiency [16,58]. Cholesterol-based lipid formulations in
lipoplexes form a rigid La
C structure and do not fuse as readily
with lipid bilayers [18,19]. These previous reports con-
Y. Zhang et al. / Biochimica et Biophysica Acta 1614 (2003) 182–192 191cerning the greater flexibility of DOPE- versus cholesterol-
based lipid formulations might explain the higher FRET
efficiencies we observed with DOPE that are consistent with
a more intimate interaction between the lipid and DNA.
In summary, the time necessary for lipid–DNA interac-
tions to stabilize is strongly dependent on the DOTAP+/
DNA ratio. Charge ratio has less effect on interactions
between DNA and cationic lipids in cholesterol-based lip-
oplexes than those in DOPE-based lipoplexes. The fact that
transfection efficiencies were also greatly affected by incu-
bation time (especially in DOPE-based lipoplexes) suggests
that incubation time should be carefully controlled just like
other experimental parameters (e.g., charge ratio) to achieve
more consistent transfection. Considering that the observed
changes in transfection cannot be attributed to alterations in
particle size, we conclude that the fluctuations observed with
FRET reflect time-dependent structural rearrangements with-
in the lipoplex that ultimately affect transfection rates. Future
studies monitoring structural rearrangements with FRET
should be useful in determining formulation parameters that
result in enhanced lipoplex stability in physiological fluids
(e.g., serum).Acknowledgments
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